Protaryx Medical Achieves Milestone with Successful Completion of First-in-Human Study of an Innovative Transseptal Puncture Technology
Baltimore, Maryland – December 11, 2024 – Protaryx Medical, a pioneer in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study, demonstrating the transformative potential of its advanced transseptal puncture technology. Conducted on December 3, 2024, at Sanatorio Italiano de Asunción in Paraguay, the study enrolled five patients under approval from the Research Ethics Committee of the Paraguayan Institute of Social Studies. The procedures were performed by Dr. Adrian Ebner, Head of the Cardiovascular…
Read MoreProtaryx™ Medical Welcomes David Mester as New CEO, Spearheading Innovative Advancements in Transseptal Access Technology
[Baltimore Maryland, September 11, 2023] – Protaryx Medical, a pioneering leader in medical device innovation, proudly announces the appointment of David Mester, MBA as its new Chief Executive Officer (CEO). With a remarkable career spanning over 30 years in the structural heart medical device industry, David Mester brings a wealth of experience and expertise to guide Protaryx into a new era of growth and innovation. Protaryx Medical is renowned for its groundbreaking Protaryx Transseptal Access Device, a cutting-edge technology that…
Read MoreProtaryx Medical Announces $8.3M in Funding
Protaryx Medical Announces $8.3M in Funding for First-in-Class Technology for Left Atrial Access in Transcatheter Cardiac Procedures
Read More